Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P De Deyn

Showing results (321-330 of 493) with videos related to

Pageof 50
Sort By:
Neurobiology of Aging|April 16, 2013
Complement receptor 1 coding variant p.Ser1610Thr in Alzheimer's disease and related endophenotypesCaroline Van Cauwenberghe, Karolien Bettens, Sebastiaan Engelborghs, et al.
Cerebrovascular Diseases Extra|April 30, 2013
A prospective study on the prevalence and risk factors of poststroke depressionA De Ryck, R Brouns, E Fransen, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|October 2, 2014
Subcortical vascular cognitive impairment, no dementia: EEG global power independently predicts vascular impairment and brain symmetry index reflects severity of cognitive declineRishi V A Sheorajpanday, Peter Mariën, Guy Nagels, et al.
Pediatric Research|March 1, 1990
Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapyB Marescau, P P De Deyn, A Lowenthal, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|April 3, 2013
EEG in silent small vessel disease: sLORETA mapping reveals cortical sources of vascular cognitive impairment no dementia in the default mode networkRishi V A Sheorajpanday, Peter Marien, Arie J T M Weeren, et al.
Journal of Alzheimer'S Disease : JAD|January 31, 2015
Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia DiagnosisHanne Struyfs, Bianca Van Broeck, Maarten Timmers, et al.
Nuclear Medicine and Biology|November 26, 2025
Integrating [<sup>11</sup>C]methylreboxetine PET and MRI to map in vivo norepinephrine transporter distribution: A proof-of-concept study of noradrenergic vulnerability in neurodegenerationJaime D Mondragon, Sofia Marcolini, Bruno Lima Giacobbo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2022
A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer's disease mouse modelNatalia Ortí-Casañ, Inge S Zuhorn, Petrus J W Naudé, et al.
Journal of Parkinson'S Disease|February 27, 2018
Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body DiseaseSygrid van der Zee, Yannick Vermeiren, Erik Fransen, et al.
EJNMMI Research|July 6, 2019
Diagnostic performance of regional cerebral blood flow images derived from dynamic PIB scans in Alzheimer's diseaseDébora E Peretti, David Vállez García, Fransje E Reesink, et al.
Pageof 50

Showing results (321-330 of 493) with videos related to

Sort By:
Pageof 50
Neurobiology of Aging|April 16, 2013
Complement receptor 1 coding variant p.Ser1610Thr in Alzheimer's disease and related endophenotypesCaroline Van Cauwenberghe, Karolien Bettens, Sebastiaan Engelborghs, et al.
Cerebrovascular Diseases Extra|April 30, 2013
A prospective study on the prevalence and risk factors of poststroke depressionA De Ryck, R Brouns, E Fransen, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|October 2, 2014
Subcortical vascular cognitive impairment, no dementia: EEG global power independently predicts vascular impairment and brain symmetry index reflects severity of cognitive declineRishi V A Sheorajpanday, Peter Mariën, Guy Nagels, et al.
Pediatric Research|March 1, 1990
Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapyB Marescau, P P De Deyn, A Lowenthal, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|April 3, 2013
EEG in silent small vessel disease: sLORETA mapping reveals cortical sources of vascular cognitive impairment no dementia in the default mode networkRishi V A Sheorajpanday, Peter Marien, Arie J T M Weeren, et al.
Journal of Alzheimer'S Disease : JAD|January 31, 2015
Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia DiagnosisHanne Struyfs, Bianca Van Broeck, Maarten Timmers, et al.
Nuclear Medicine and Biology|November 26, 2025
Integrating [<sup>11</sup>C]methylreboxetine PET and MRI to map in vivo norepinephrine transporter distribution: A proof-of-concept study of noradrenergic vulnerability in neurodegenerationJaime D Mondragon, Sofia Marcolini, Bruno Lima Giacobbo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2022
A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer's disease mouse modelNatalia Ortí-Casañ, Inge S Zuhorn, Petrus J W Naudé, et al.
Journal of Parkinson'S Disease|February 27, 2018
Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body DiseaseSygrid van der Zee, Yannick Vermeiren, Erik Fransen, et al.
EJNMMI Research|July 6, 2019
Diagnostic performance of regional cerebral blood flow images derived from dynamic PIB scans in Alzheimer's diseaseDébora E Peretti, David Vállez García, Fransje E Reesink, et al.
Pageof 50